This week’s bulletin is later than usual as we’re attending Horizons’ 14th annual conference in New York City. But, there’s plenty to cover: MAPS’ new funding stream, atai’s increased stake in COMPASS Pathways, a study on the interaction between an SSRI and psilocybin, and more… At the close of Thursday’s Business Forum here at Horizons, Vine Ventures’ Ryan Zurrer announced The Regenerative…
